125 related articles for article (PubMed ID: 11171045)
1. Tunicamycin induces ubiquitination and degradation of apolipoprotein B in HepG2 cells.
Liao W; Chan L
Biochem J; 2001 Feb; 353(Pt 3):493-501. PubMed ID: 11171045
[TBL] [Abstract][Full Text] [Related]
2. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
Liao W; Yeung SC; Chan L
J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244
[TBL] [Abstract][Full Text] [Related]
3. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
Zhou M; Fisher EA; Ginsberg HN
J Biol Chem; 1998 Sep; 273(38):24649-53. PubMed ID: 9733761
[TBL] [Abstract][Full Text] [Related]
4. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
5. Studies on degradative mechanisms mediating post-translational fragmentation of apolipoprotein B and the generation of the 70-kDa fragment.
Cavallo D; Rudy D; Mohammadi A; Macri J; Adeli K
J Biol Chem; 1999 Aug; 274(33):23135-43. PubMed ID: 10438483
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells.
Liao W; Chan L
J Biol Chem; 2000 Feb; 275(6):3950-6. PubMed ID: 10660549
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells.
Sakata N; Stoops JD; Dixon JL
J Biol Chem; 1999 Jun; 274(24):17068-74. PubMed ID: 10358059
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
Yeung SJ; Chen SH; Chan L
Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
[TBL] [Abstract][Full Text] [Related]
9. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes.
Taghibiglou C; Rudy D; Van Iderstine SC; Aiton A; Cavallo D; Cheung R; Adeli K
J Lipid Res; 2000 Apr; 41(4):499-513. PubMed ID: 10744770
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
Liao W; Chang BH; Mancini M; Chan L
J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
[TBL] [Abstract][Full Text] [Related]
11. Translocation efficiency, susceptibility to proteasomal degradation, and lipid responsiveness of apolipoprotein B are determined by the presence of beta sheet domains.
Liang J; Wu X; Jiang H; Zhou M; Yang H; Angkeow P; Huang LS; Sturley SL; Ginsberg H
J Biol Chem; 1998 Dec; 273(52):35216-21. PubMed ID: 9857060
[TBL] [Abstract][Full Text] [Related]
12. Co-translational interactions of apoprotein B with the ribosome and translocon during lipoprotein assembly or targeting to the proteasome.
Pariyarath R; Wang H; Aitchison JD; Ginsberg HN; Welch WJ; Johnson AE; Fisher EA
J Biol Chem; 2001 Jan; 276(1):541-50. PubMed ID: 11022045
[TBL] [Abstract][Full Text] [Related]
13. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
Macri J; Adeli K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
[TBL] [Abstract][Full Text] [Related]
14. The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70.
Fisher EA; Zhou M; Mitchell DM; Wu X; Omura S; Wang H; Goldberg AL; Ginsberg HN
J Biol Chem; 1997 Aug; 272(33):20427-34. PubMed ID: 9252351
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E in macrophages and hepatocytes is eegraded via the proteasomal pathway.
Wenner C; Lorkowski S; Engel T; Cullen P
Biochem Biophys Res Commun; 2001 Mar; 282(2):608-14. PubMed ID: 11401504
[TBL] [Abstract][Full Text] [Related]
16. Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48.
Lindén D; Lindberg K; Oscarsson J; Claesson C; Asp L; Li L; Gustafsson M; Borén J; Olofsson SO
J Biol Chem; 2002 Jun; 277(25):23044-53. PubMed ID: 11925428
[TBL] [Abstract][Full Text] [Related]
17. Efficient glycosylation site utilization by intracellular apolipoprotein B. Implications for proteasomal degradation.
Huang XF; Shelness GS
J Lipid Res; 1999 Dec; 40(12):2212-22. PubMed ID: 10588947
[TBL] [Abstract][Full Text] [Related]
18. Translocation-arrested apolipoprotein B evades proteasome degradation via a sterol-sensitive block in ubiquitin conjugation.
Du EZ; Fleming JF; Wang SL; Spitsen GM; Davis RA
J Biol Chem; 1999 Jan; 274(3):1856-62. PubMed ID: 9880570
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of biphasic effects of docosahexaenoic acid on apolipoprotein B secretion in HepG2 cells.
Wu X; Shang A; Jiang H; Ginsberg HN
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3347-55. PubMed ID: 9409332
[TBL] [Abstract][Full Text] [Related]
20. Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway.
White AL; Guerra B; Wang J; Lanford RE
J Lipid Res; 1999 Feb; 40(2):275-86. PubMed ID: 9925657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
